Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 24, 2001

View Archived Issues

Study In Twins Points To Role Of Genetic Heart Disease Factors

London Exchange Might Ease Listing Rules For Young Firms

GPC, Byk Gulden Collaborate In Deal Worth Up To US$100M

European Bioethics Committee Starts Work, Elects President

Belgian Firms Tibotec, Virco Plan To Add Mass Via Merger

Strong Placebo Effect In Phase II Causes Failed Phytopharm Trial

IsoTis Completes Implants Of Autologous Living Bone Tissue

European Pharma Industry Calls For New Evaluation Structure

Other News To Note

Biotran Completes Australian IPO To Fund Diagnostics, HIV Product

NiCox Reveals 'Aggressive' Plan For Compounds In Coming Year

Cerep, Four European Companies Align To Create Compound Library

Genset Subscribes To Celera Products For Genomics Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...